Press releases
- Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies
- Harbour BioMed Reports Full Year 2023 Financial Results
- Nona Biosciences Enters into Collaboration Agreement with Boostimmune in Antibody-Drug Conjugate Development
Key statistics
On Thursday, Hbm Holdings Ltd (2142:HKG.HZ) closed at 1.55, -23.65% below its 52-week high of 2.03, set on Aug 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.61 |
---|---|
High | 1.67 |
Low | 1.46 |
Bid | 1.53 |
Offer | 1.55 |
Previous close | 1.40 |
Average volume | 3.46m |
---|---|
Shares outstanding | 768.49m |
Free float | 610.36m |
P/E (TTM) | 5.78 |
Market cap | 1.08bn HKD |
EPS (TTM) | 0.242 HKD |
Data delayed at least 15 minutes, as of May 23 2024.
More ▼